Contrasting Glucose Health (GLUC) and Its Rivals

Glucose Health (OTCMKTS:GLUC) is one of 53 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it compare to its peers? We will compare Glucose Health to related businesses based on the strength of its dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk.

Risk & Volatility

Glucose Health has a beta of 3.51, meaning that its stock price is 251% more volatile than the S&P 500. Comparatively, Glucose Health’s peers have a beta of 1.20, meaning that their average stock price is 20% more volatile than the S&P 500.

Earnings & Valuation

This table compares Glucose Health and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Glucose Health	$540,000.00	-$420,000.00	-6.29
Glucose Health Competitors	$323.80 million	-$49.81 million	-16.11

Glucose Health’s peers have higher revenue, but lower earnings than Glucose Health. Glucose Health is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a summary of current recommendations and price targets for Glucose Health and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glucose Health	0	0	0	0	N/A
Glucose Health Competitors	272	555	993	74	2.46

As a group, “Medicinals & botanicals” companies have a potential upside of 48.67%. Given Glucose Health’s peers higher possible upside, analysts clearly believe Glucose Health has less favorable growth aspects than its peers.

Profitability

This table compares Glucose Health and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Glucose Health	-75.00%	N/A	N/A
Glucose Health Competitors	-41.35%	-262.15%	-7.81%

Institutional & Insider Ownership

15.8% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 21.3% of shares of all “Medicinals & botanicals” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Glucose Health peers beat Glucose Health on 5 of the 9 factors compared.

Glucose Health Company Profile

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.